KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $363,571 | +8.3% | 37,754 | +1.2% | 0.05% | 0.0% |
| Q2 2023 | $335,754 | +14.4% | 37,306 | -0.1% | 0.05% | +15.0% |
| Q1 2023 | $293,500 | -7.7% | 37,341 | -20.6% | 0.04% | -21.6% |
| Q4 2022 | $318,017 | +128.8% | 47,044 | +233.3% | 0.05% | +325.0% |
| Q2 2022 | $139,000 | -29.8% | 14,113 | -13.5% | 0.01% | -7.7% |
| Q2 2020 | $198,000 | +33.8% | 16,325 | -15.4% | 0.01% | +8.3% |
| Q1 2020 | $148,000 | -65.3% | 19,300 | -19.4% | 0.01% | -53.8% |
| Q4 2019 | $427,000 | – | 23,952 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 589,270 | $8,686,000 | 5.61% |
| GREAT POINT PARTNERS LLC | 874,197 | $12,886,000 | 3.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 383,233 | $10,805,000 | 2.44% |
| Frazier Life Sciences Management, L.P. | 1,572,192 | $23,174,000 | 1.98% |
| TANG CAPITAL MANAGEMENT LLC | 648,269 | $9,555,000 | 1.91% |
| Deep Track Capital, LP | 1,729,757 | $25,497,000 | 1.64% |
| Vivo Capital, LLC | 1,533,559 | $22,605,000 | 1.56% |
| Monashee Investment Management LLC | 264,111 | $3,893,000 | 1.13% |
| COMMODORE CAPITAL LP | 312,553 | $4,607,000 | 1.03% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,746,300 | $25,740,000 | 0.79% |